` BAYZF (Bayer AG) vs SAN (Sanofi SA) Comparison - Alpha Spread

BAYZF
vs
SAN

Over the past 12 months, BAYZF has significantly outperformed SAN, delivering a return of +95% compared to the SAN's 10% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BAYZF
SAN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BAYZF Intrinsic Value
LOCKED
Unlock
SAN Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Bayer AG
OTC:BAYZF
47.82 USD
Sanofi SA
PAR:SAN
82.06 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BAYZF, SAN

BAYZF
SAN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Bayer AG
Revenue
Sanofi SA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BAYZF, SAN

BAYZF
SAN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Bayer AG
OTC:BAYZF
Sanofi SA
PAR:SAN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BAYZF
58.8%
SAN
72.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

Operating Margin

BAYZF
13.1%
SAN
21.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

Net Margin

BAYZF
-7.9%
SAN
16.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

FCF Margin

BAYZF
7.5%
SAN
23.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

ROE

BAYZF
-12.5%
SAN
10.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

ROA

BAYZF
-3.4%
SAN
6%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

ROIC

BAYZF
7.4%
SAN
7.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

ROCE

BAYZF
7.8%
SAN
10%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BAYZF, SAN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BAYZF, SAN

Performance Gap Between BAYZF and SAN
LOCKED
Unlock

Performance By Year
BAYZF, SAN

Loading
BAYZF
SAN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BAYZF to other stocks
AZN
AstraZeneca PLC
More expensive
vs BAYZF
ROG
Roche Holding AG
More expensive
vs BAYZF
NOVO B
Novo Nordisk A/S
More expensive
vs BAYZF
ZTS
Zoetis Inc
More expensive
vs BAYZF
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett